Gerd-Rüdiger R Burmester (Gerd R Burmester, Gerd Rüdiger Burmester, Gerd Rüdiger Burmester, Gerd-Rüdiger Burmester, Gerd Burmester)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 102

Top Venues

RMD open

Annals of the rheumatic diseases

Rheumatology and therapy

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Gerd-Rüdiger R Burmester, Filip E Van den Bosch, Diamant Thaҫi, Anna K Shmagel, Yanxi Liu, Nasser Khan, Heidi S Camp, Alan J Kivitz
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT). The Journal of rheumatology 51 (7) (2024)
Gerd-Rüdiger R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S Gensler
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and therapy (2024)
Gerd-Rüdiger R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S Gensler
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and therapy 11 (3) (2024)
Gerd-Rüdiger R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S Gensler
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and therapy 11 (3) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Esha Kadam, Mahnoor Javaid, Parikshit Sen, Sreoshy Saha, Nelly Ziadé, Jessica A Day, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Tulika Chatterjee, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Battista Simone, Karen Cheng, Peter Boyd, Linda Kobert, Abraham Edgar Gracia-Ramos, Srijan Mittal, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Francis Guillemin, Elena Nikiphorou, Gabriela Arredondo Hector Chinoy, Vikas Gupta, Latika Gupta, null null
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies. Rheumatology international (2024)
Masataka Kuwana, Naitica Darooka, Sreoshy Saha, Sarah Dyball, Parikshit Sen, Praggya Yaadav, Mahnoor Javaid, Esha Kadam, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Nelly Ziadé, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Francis Guillemin, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Abraham Edgar Gracia-Ramos, Elena Nikiphorou, Jessica A Day, Gabriela Arredondo Hector Chinoy, Rohit Aggarwal, Vikas Agarwal, Latika Gupta, null null
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases 27 (5) (2024)
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, Ernest H S Choy, Daniel E Furst, Jiri Vencovsky, Anthony G Wilson, Gerd-Rüdiger R Burmester, Derek Coombs, Sara K Penn, Nasser Khan, Jillian B Yee, Kassim Rahawi, Iain B McInnes
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and therapy 11 (1) (2024)
Esha Kadam, Mahnoor Javaid, Parikshit Sen, Sreoshy Saha, Nelly Ziadé, Jessica A Day, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Tulika Chatterjee, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Battista Simone, Karen Cheng, Peter Boyd, Linda Kobert, Abraham Edgar Gracia-Ramos, Srijan Mittal, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Francis Guillemin, Elena Nikiphorou, Gabriela Arredondo Hector Chinoy, Vikas Gupta, Latika Gupta, null null
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies. Rheumatology international 44 (7) (2024)
Esha Kadam, Mahnoor Javaid, Parikshit Sen, Sreoshy Saha, Nelly Ziadé, Jessica A Day, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Tulika Chatterjee, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Battista Simone, Karen Cheng, Peter Boyd, Linda Kobert, Abraham Edgar Gracia-Ramos, Srijan Mittal, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Francis Guillemin, Elena Nikiphorou, Gabriela Arredondo Hector Chinoy, Vikas Gupta, Latika Gupta, null null
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies. Rheumatology international 44 (7) (2024)
Masataka Kuwana, Naitica Darooka, Sreoshy Saha, Sarah Dyball, Parikshit Sen, Praggya Yaadav, Mahnoor Javaid, Esha Kadam, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Nelly Ziadé, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Francis Guillemin, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Abraham Edgar Gracia-Ramos, Elena Nikiphorou, Jessica A Day, Gabriela Arredondo Hector Chinoy, Rohit Aggarwal, Vikas Agarwal, Latika Gupta, null null
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases 27 (5) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Esha Kadam, Mahnoor Javaid, Parikshit Sen, Sreoshy Saha, Nelly Ziadé, Jessica A Day, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Tulika Chatterjee, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Battista Simone, Karen Cheng, Peter Boyd, Linda Kobert, Abraham Edgar Gracia-Ramos, Srijan Mittal, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Francis Guillemin, Elena Nikiphorou, Gabriela Arredondo Hector Chinoy, Vikas Gupta, Latika Gupta, null null
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies. Rheumatology international 44 (7) (2024)
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, Ernest H S Choy, Daniel E Furst, Jiri Vencovsky, Anthony G Wilson, Gerd-Rüdiger R Burmester, Derek Coombs, Sara K Penn, Nasser Khan, Jillian B Yee, Kassim Rahawi, Iain B McInnes
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and therapy 11 (1) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
Masataka Kuwana, Naitica Darooka, Sreoshy Saha, Sarah Dyball, Parikshit Sen, Praggya Yaadav, Mahnoor Javaid, Esha Kadam, Samuel Katsuyuki Shinjo, Dzifa Dey, Lorenzo Cavagna, Ashima Makol, Carlos Enrique Toro Gutiérrez, Carlo V Caballero Uribe, Masataka Kuwana, Gerd-Rüdiger R Burmester, Nelly Ziadé, Chris Wincup, Laura Andreoli, Ioannis Parodis, Ai Lyn Tan, Francis Guillemin, Johannes Knitza, Guo-Chun Wang, Nicola Dalbeth, Tsvetelina V Velikova, Abraham Edgar Gracia-Ramos, Elena Nikiphorou, Jessica A Day, Gabriela Arredondo Hector Chinoy, Rohit Aggarwal, Vikas Agarwal, Latika Gupta, null null
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges. International journal of rheumatic diseases 27 (5) (2024)
Gerd-Rüdiger R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S Gensler
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and therapy 11 (3) (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases (2024)
Gerd-Rüdiger R Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S Gensler
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatology and therapy 11 (3) (2024)
Gerd-Rüdiger R Burmester, Filip E Van den Bosch, Diamant Thaҫi, Anna K Shmagel, Yanxi Liu, Nasser Khan, Heidi S Camp, Alan J Kivitz
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT). The Journal of rheumatology 51 (7) (2024)
Bayram Farisoğulları, Saskia Lawson-Tovey, Kimmie L Hyrich, Laure Gossec, Loreto Carmona, Anja Strangfeld, Elsa F Mateus, Martin Schaefer, Ana Rodrigues, Eric Hachulla, José A Gómez-Puerta, Marta Mosca, Patrick Durez, Ludovic Trefond, Tiphaine Goulenok, Martina Cornalba, Emoke Stenova, Inita Bulina, Eva Strakova, Julija Zepa, Nicolas Roux, Olivier Brocq, Eric Veillard, Gerd-Rüdiger R Burmester, Xavier Mariette, Pedro M Machado, null null
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry. Annals of the rheumatic diseases (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Gerd-Rüdiger R Burmester, Filip E Van den Bosch, Diamant Thaҫi, Anna K Shmagel, Yanxi Liu, Nasser Khan, Heidi S Camp, Alan J Kivitz
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT). The Journal of rheumatology (2024)
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, Ernest H S Choy, Daniel E Furst, Jiri Vencovsky, Anthony G Wilson, Gerd-Rüdiger R Burmester, Derek Coombs, Sara K Penn, Nasser Khan, Jillian B Yee, Kassim Rahawi, Iain B McInnes
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and therapy (2024)
Gerd-Rüdiger R Burmester
Celebrating the global impact of rheumatology research: preface to the Viewpoint Article-'What are the hot topics in Japanese rheumatology?-Go above and beyond' by Yoshiya Tanaka, Japan. RMD open 9 (1) (2023)
Roy Fleischmann, Jeffrey R Curtis, Christina Charles-Schoeman, Eduardo Mysler, Kunihiro Yamaoka, Christophe Richez, Hannah Palac, Deanne Dilley, Jianzhong Liu, Sander Strengholt, Gerd-Rüdiger R Burmester
Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Annals of the rheumatic diseases (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Maarten H P Butink, Casper Webers, Suzanne M M Verstappen, Louise Falzon, Neil Betteridge, Dieter Wiek, Anthony D Woolf, Tanja Alexandra Stamm, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Robin Christensen, Annelies Boonen
Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation. RMD open 9 (1) (2023)
Eric L Matteson, Marco Matucci Cerinic, Michael Kreuter, Gerd-Rüdiger R Burmester, Philippe Dieude, Paul Emery, Yannick Allanore, Janet E Pope, Dinesh Khanna
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD open 9 (3) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Laura C Coates, Gerd-Rüdiger R Burmester
Axial psoratic arthritis: are you a lumper or a splitter? RMD open 9 (2) (2023)
Gerd-Rüdiger R Burmester
Celebrating the global impact of rheumatology research: preface to the Viewpoint Article-'What are the hot topics in Japanese rheumatology?-Go above and beyond' by Yoshiya Tanaka, Japan. RMD open 9 (1) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Alexander Tobias, Lennard Ostendorf, Robert Biesen, Udo Schneider, Gerd-Rüdiger R Burmester, Falk Hiepe
Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus. Annals of the rheumatic diseases (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Jeffrey R Curtis, Paul Emery, Bryan Downie, Yan Zhong, Jinfeng Liu, Ling Han, Rachael E Hawtin, Gerd-Rüdiger R Burmester
Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis. Rheumatology and therapy (2023)
Thomas Häupl, Till Sörensen, Biljana Smiljanovic, Marine Darcy, Justus Scheder-Bieschin, Nico Steckhan, Anika M Hartmann, Daniela A Koppold, Bruno Stuhlmüller, Karl Skriner, Barbara M Walewska, Berthold Hoppe, Marc Bonin, Gerd-Rüdiger R Burmester, Pascal Schendel, Eugen Feist, Karsten Liere, Martin Meixner, Christian Kessler, Andreas Grützkau, Andreas Michalsen
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid Arthritis. Journal of clinical medicine 12 (13) (2023)
Laura C Coates, Gerd-Rüdiger R Burmester
Axial psoratic arthritis: are you a lumper or a splitter? RMD open 9 (2) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Maarten H P Butink, Casper Webers, Suzanne M M Verstappen, Louise Falzon, Neil Betteridge, Dieter Wiek, Anthony D Woolf, Tanja Alexandra Stamm, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Robin Christensen, Annelies Boonen
Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester
Celebrating the global impact of rheumatology research: preface to the Viewpoint Article-'What are the hot topics in Japanese rheumatology?-Go above and beyond' by Yoshiya Tanaka, Japan. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Vibeke Strand, Alan J Kivitz, Chih-Chi Hu, Sheldon Wang, Hubert van Hoogstraten, Gabriella L Klier, Roy Fleischmann
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis. Rheumatology (Oxford, England) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik Nils Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander Ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger R Burmester, Robert Biesen
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases. Annals of the rheumatic diseases 81 (6) (2022)
Kastriot Kastrati, Daniel Aletaha, Gerd-Rüdiger R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke J H Voshaar, Kevin L Winthrop, Josef S Smolen, Andreas Kerschbaumer
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD open 8 (2) (2022)
Gerd-Rüdiger R Burmester, Bernhard Manger, Larissa Valor-Méndez, Hendrik Schulze-Koops
Joachim Robert Kalden: one of the founders of autoimmunity research and immunotherapy. Annals of the rheumatic diseases 80 (6) (2022)
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger R Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco, Frank Buttgereit
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Annals of the rheumatic diseases (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Annelies Boonen, Casper Webers, Maarten H P Butink, Birgit Barten, Neil Betteridge, Dame Carol Black, Ann Bremander, Boryana Boteva, Olga Brzezińska, Lina Chauhan, Sarah Copsey, Vera Guimarães, Monique Gignac, Jennifer Glaysher, Frans Green, Jan L Hoving, Mary Lucy Marques, Hana Smucrova, Tanja Alexandra Stamm, Dieter Wiek, Ross Wilkie, Anthony D Woolf, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Suzanne M M Verstappen
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work. Annals of the rheumatic diseases (2022)
Julia Schally, Henning Christian Brandt, Jan Brandt-Jürgens, Gerd-Rüdiger R Burmester, Hildrun Haibel, Henriette Käding, Kirsten Karberg, Susanne Lüders, Burkhard Muche, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torğutalp, Maryna Verba, Silke Zinke, Denis Poddubnyy, Fabian Proft
Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study. Therapeutic advances in musculoskeletal disease 14 (2022)
Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd-Rüdiger R Burmester, Hildrun Haibel, Henriette Käding, Kirsten Karberg, Susanne Lüders, Burkhard Muche, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Maryna Verba, Silke Zinke, Denis Poddubnyy
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study. RMD open 8 (2) (2022)
Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd-Rüdiger R Burmester, Hildrun Haibel, Henriette Käding, Kirsten Karberg, Susanne Lüders, Burkhard Muche, Mikhail Protopopov, Judith Rademacher, Valeria Rios Rodriguez, Murat Torğutalp, Maryna Verba, Silke Zinke, Denis Poddubnyy
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study. Therapeutic advances in musculoskeletal disease 14 (2022)
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander Ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif-Erik Sander, Gerd-Rüdiger R Burmester, Florian Klein, Robert Biesen
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination. RMD open 8 (2) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Manuel Graf, Sae Lim von Stuckrad, Akinori Uruha, Jens Klotsche, Lydia Zorn-Pauly, Nadine Unterwalder, Thomas Buttgereit, Krusche Martin, Christian Meisel, Gerd-Rüdiger R Burmester, Falk Hiepe, Robert Biesen, Tilmann Kallinich, Werner Stenzel, Udo Schneider, Thomas Rose
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD open 8 (1) (2022)
Robert B M Landewe, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes W J Bijlsma, Gerd-Rüdiger R Burmester, Roberto Caporali, Bernard Combe, Richard P Conway, Jeffrey R Curtis, Ori Elkayam, Laure Gossec, Marloes W Heijstek, Lukas Haupt, AnnaMaria Iagnocco, John Dudley Isaacs, István Ábel Juhász, Suzi Makri, Xavier Mariette, Iain B McInnes, Puja Mehta, Ulf Mueller-Ladner, Hendrik Schulze-Koops, Josef S Smolen, Dieter Wiek, Kevin L Winthrop, Victoria Navarro-Compán, Pedro M Machado
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Annals of the rheumatic diseases 81 (12) (2022)
Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure. Annals of the rheumatic diseases 81 (7) (2022)
Johanna Mucke, Martin Krusche, Gerd-Rüdiger R Burmester
A broad look into the future of rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 14 (2022)
Fredrik Nils Albach, Gerd-Rüdiger R Burmester, Robert Biesen
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response. Annals of the rheumatic diseases 80 (10) (2021)
Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd-Rüdiger R Burmester, Jüergen Braun, Martin Schäfer, Angela Zink, Anja Strangfeld
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Annals of the rheumatic diseases (2021)
Kevin L Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, Alan Kivitz, Franziska Matzkies, Mark C Genovese, Deyuan Jiang, Kun Chen, Beatrix Bartok, Angelika Jahreis, Robin Besuyen, Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years. Annals of the rheumatic diseases (2021)
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimmie L Hyrich, Laure Gossec, Loreto Carmona, Ana Rodrigues, Nicolas Roux, Catia Duarte, Eric Hachulla, Eric Veillard, Eva Strakova, Gerd-Rüdiger R Burmester, Gözde Kübra Yardımcı, José A Gómez-Puerta, Julija Zepa, Lianne Kearsley-Fleet, Ludovic Trefond, Maria Cunha, Marta Mosca, Martina Cornalba, Martin Soubrier, Nicolas Roux, Olivier Brocq, Patrick Durez, Richard P Conway, Tiphaine Goulenok, Johannes W J Bijlsma, Iain B McInnes, Xavier Mariette
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Annals of the rheumatic diseases 81 (5) (2021)
Schahrasad Lisa Ridha Ali, Anne-Marie Glimm, Gerd-Rüdiger R Burmester, Paula Hoff, Gabriela Schmittat, Sandra Hermann, Marina Backhaus, Jens Klotsche, Sarah Ohrndorf
Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study. BMJ open 11 (8) (2021)
Daniel Aletaha, René Westhovens, Cecile Gaujoux-Viala, Giovanni Adami, Alan Matsumoto, Paul Bird, Osvaldo Daniel Messina, Maya H Buch, Beatrix Bartok, Zhaoyu Yin, Ying Guo, Thijs Hendrikx, Gerd-Rüdiger R Burmester
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. RMD open 7 (2) (2021)
Rosaria Talarico, Diana Marinello, Stefano Bombardieri, Gerd-Rüdiger R Burmester, Joao Fonseca, Charissa Frank, Ilaria Galetti, Eric Hachulla, Frederic Houssiau, Ulf Mueller-Ladner, Matthias Schneider, Vanessa Smith, Giuseppe Turchetti, Jacob M van Laar, Ana Vieira, Maurizio Cutolo, Marta Mosca
Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey. RMD open 6 (2) (2021)
Claudia Kedor, Jacqueline Detert, Rolf Rau, Siegfried Wassenberg, Joachim Listing, Pascal Klaus, Tanja Braun, Walter Hermann, Stefan Markus Weiner, Frank Buttgereit, Gerd-Rüdiger R Burmester
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD open 7 (2) (2021)
Khetam Ghannam, Lorena Martinez Gamboa, Claudia Kedor, Lydia Spengler, Ulrike Kuckelkorn, Thomas Häupl, Gerd-Rüdiger R Burmester, Eugen Feist
Response to abatacept is associated with the inhibition of proteasome β1i expression in T cells of patients with rheumatoid arthritis. RMD open 6 (3) (2021)
Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd-Rüdiger R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John Dudley Isaacs, Isabelle Kone-Paut, César Magro-Checa, Iain B McInnes, Pier Luigi Meroni, Luca Quartuccio, A V Ramanan, Manuel Ramos-Casals, Javier Rodríguez Carrio, Hendrik Schulze-Koops, Tanja Alexandra Stamm, Sander W Tas, Benjamin Terrier, Dennis G McGonagle, Xavier Mariette
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the rheumatic diseases (2021)
Ali Berkant Avci, Eugen Feist, Gerd-Rüdiger R Burmester
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 13 (2021)
Philip Gerard Conaghan, Eduardo Mysler, Yoshiya Tanaka, Barbara Da Silva-Tillmann, Tim Shaw, John Liu, Ryan Ferguson, Jeffrey V Enejosa, Stanley B Cohen, Peter Nash, William F C Rigby, Gerd-Rüdiger R Burmester
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program. Drug safety 44 (5) (2021)
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd-Rüdiger R Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao, Mark C Genovese
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. RMD open 6 (1) (2021)
Gerd-Rüdiger R Burmester, Kevin Winthrop, Ricardo Blanco, Peter Nash, Philippe Goupille, Valderilio F Azevedo, Carlo Salvarani, Andrea Rubbert-Roth, Elizabeth Lesser, Ralph Lippe, Apinya Lertratanakul, Reva M Mccaskill, John Liu, Eric M Ruderman
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. Rheumatology and therapy 9 (2) (2021)
Hector Rincon-Arevalo, Mira Choi, Ana Luisa Stefanski, Fabian Halleck, Ulrike Weber, Franziska Szelinski, Bernd Jahrsdörfer, Hubert Schrezenmeier, Carolin Ludwig, Arne Sattler, Katja Kotsch, Alexander Potekhin, Yidan Chen, Gerd-Rüdiger R Burmester, Kai Uwe Eckardt, Gabriela Maria Guerra, Pawel Durek, Frederik Heinrich, Marta Ferreira-Gomes, Andreas Radbruch, Klemens Budde, Andreia C Lino, Mir-Farzin Mashreghi, Eva Schrezenmeier, Thomas Dörner
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Science immunology 6 (60) (2021)
Gerd-Rüdiger R Burmester, Vivian P Bykerk, Maya H Buch, Yoshiya Tanaka, Hideto Kameda, Amy Praestgaard, Hubert van Hoogstraten, Antonio Fernandez-Nebro, Thomas Huizinga
Sarilumab monotherapy versus sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis. Rheumatology (Oxford, England) (2021)
Peter C Taylor, Tsutomu Takeuchi, Gerd-Rüdiger R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, Jorge Ross Terres, Natalia Bello, Kevin L Winthrop
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Annals of the rheumatic diseases (2021)
Sarah Ohrndorf, Anne-Marie Glimm, Mads Ammitzbøll Danielsen, Mikkel Ostergaard, Gerd-Rüdiger R Burmester
Fluorescence optical imaging: ready for prime time? RMD open 7 (2) (2021)
Georgios Kokolakis, Robert Sabat, Imma Fischer, Susana Gomis-Kleindienst, Björn Fritz, Gerd-Rüdiger R Burmester, Kamran Ghoreschi, Sarah Ohrndorf
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis-Real-World Data from Dermatology Practice. Journal of personalized medicine 11 (11) (2021)
Kim Lauper, Johannes W J Bijlsma, Gerd-Rüdiger R Burmester
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic. Annals of the rheumatic diseases 80 (1) (2020)
John Dudley Isaacs, Gerd-Rüdiger R Burmester
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs. Annals of the rheumatic diseases 79 (8) (2020)
Gerd-Rüdiger R Burmester, Kenneth B Gordon, James T Rosenbaum, Dilek Arikan, Winnie L Lau, Peigang Li, Freddy Faccin, Remo Panaccione
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. Advances in therapy 37 (1) (2019)
Aurélie Najm, Elena Nikiphorou, Marie Kostine, Christophe Richez, John D Pauling, Axel Finckh, Valentin Ritschl, Yeliz Prior, Petra Balážová, Simon Stones, Zoltan Szekanecz, Annamaria Iagnocco, Sofia Ramiro, Francisca Sivera, Maxime Dougados, Loreto Carmona, Gerd-Rüdiger R Burmester, Dieter Wiek, Laure Gossec, Francis Berenbaum
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. RMD open 5 (2) (2019)
Joanna Kedra, Timothy Radstake, Aridaman Pandit, Xenofon Baraliakos, Francis Berenbaum, Axel Finckh, Bruno Fautrel, Tanja Alexandra Stamm, David Gomez-Cabrero, Christian Pristipino, Remy Choquet, Hervé Servy, Simon Stones, Gerd-Rüdiger R Burmester, Laure Gossec
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations. RMD open 5 (2) (2019)
Gerd-Rüdiger R Burmester, Vibeke Strand, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Gregory St John, Susan Boklage, Mark C Genovese
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension. RMD open 5 (2) (2019)
Walter P Maksymowych, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée Mfm van der Heijde, Robert G W Lambert, Ori Elkayam, Josef S Smolen, J Carter Throne, Maggie J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd-Rüdiger R Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl C M Barnabe, Clifton O Bingham, Paul P Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Alexandre Sepriano, Robert Landewé
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA. The Journal of rheumatology 47 (6) (2019)
Alexandre Sepriano, Josef S Smolen, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée Mfm van der Heijde, Ori Elkayam, J Carter Throne, Maggie J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd-Rüdiger R Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl C M Barnabe, Clifton O Bingham, Paul P Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Robert B M Landewe, Walter P Maksymowych
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort. The Journal of rheumatology 47 (6) (2019)

Gerd-Rüdiger R Burmester.css-eqlu8i{font-size:small;padding-left:4px;} (Gerd R Burmester, Gerd Rüdiger Burmester, Gerd Rüdiger Burmester, Gerd-Rüdiger Burmester, Gerd Burmester)

Publication Activity (10 Years)

Top Topics

Top Venues

Gerd-Rüdiger R Burmester (Gerd R Burmester, Gerd Rüdiger Burmester, Gerd Rüdiger Burmester, Gerd-Rüdiger Burmester, Gerd Burmester)